The extent of mitotic death is particularly dependent on the ratio of Bcl-xL/Bak, as a 2-fold difference in this ratio can already distinguish cancer lines that are resistant (e.g., U-2 OS) and sensitive (e.g., HeLa) to mitotic death. The gene discussed is BCL2L1; the disease is cancer.